Sehn LH - Search Results

1

A phase II study of BTI-322, a monoclonal anti-CD2 antibody, for treatment of steroid-resistant acute graft-versus-host disease.

Przepiorka D, Phillips GL, Ratanatharathorn V, Cottler-Fox M, Sehn LH, Antin JH, LeBherz D, Awwad M, Hope J, McClain JB. Przepiorka D, et al. Among authors: sehn lh. Blood. 1998 Dec 1;92(11):4066-71. Blood. 1998. PMID: 9834211 Free article. Clinical Trial.

2

Primary diffuse large B-cell lymphoma of the mediastinum: outcome following high-dose chemotherapy and autologous hematopoietic cell transplantation.

Sehn LH, Antin JH, Shulman LN, Mauch P, Elias A, Kadin ME, Wheeler C. Sehn LH, et al. Blood. 1998 Jan 15;91(2):717-23. Blood. 1998. PMID: 9427731 Free article.

3

Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: impact of donor lymphocyte infusion.

Sehn LH, Alyea EP, Weller E, Canning C, Lee S, Ritz J, Antin JH, Soiffer RJ. Sehn LH, et al. J Clin Oncol. 1999 Feb;17(2):561-8. doi: 10.1200/JCO.1999.17.2.561. J Clin Oncol. 1999. PMID: 10080600 Clinical Trial.

4

Pancreatitis during therapy of acute myeloid leukemia: cytarabine related?

McGrail LH, Sehn LH, Weiss RB, Robson MR, Antin JH, Byrd JC. McGrail LH, et al. Among authors: sehn lh. Ann Oncol. 1999 Nov;10(11):1373-6. doi: 10.1023/a:1008342320532. Ann Oncol. 1999. PMID: 10631468 Free article.

5

A phase 1 study of obinutuzumab induction followed by 2 years of maintenance in patients with relapsed CD20-positive B-cell malignancies.

Sehn LH, Assouline SE, Stewart DA, Mangel J, Gascoyne RD, Fine G, Frances-Lasserre S, Carlile DJ, Crump M. Sehn LH, et al. Blood. 2012 May 31;119(22):5118-25. doi: 10.1182/blood-2012-02-408773. Epub 2012 Mar 20. Blood. 2012. PMID: 22438256 Free article. Clinical Trial.

6

CAR T cells as a second-line therapy for large B-cell lymphoma: a paradigm shift?

Westin J, Sehn LH. Westin J, et al. Among authors: sehn lh. Blood. 2022 May 5;139(18):2737-2746. doi: 10.1182/blood.2022015789. Blood. 2022. PMID: 35240677 Free article. Review.

7

Rapid infusion rituximab in combination with corticosteroid-containing chemotherapy or as maintenance therapy is well tolerated and can safely be delivered in the community setting.

Sehn LH, Donaldson J, Filewich A, Fitzgerald C, Gill KK, Runzer N, Searle B, Souliere S, Spinelli JJ, Sutherland J, Connors JM. Sehn LH, et al. Blood. 2007 May 15;109(10):4171-3. doi: 10.1182/blood-2006-11-059469. Epub 2007 Jan 23. Blood. 2007. PMID: 17244675 Free article. Clinical Trial.

8

Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival.

Johnson NA, Boyle M, Bashashati A, Leach S, Brooks-Wilson A, Sehn LH, Chhanabhai M, Brinkman RR, Connors JM, Weng AP, Gascoyne RD. Johnson NA, et al. Among authors: sehn lh. Blood. 2009 Apr 16;113(16):3773-80. doi: 10.1182/blood-2008-09-177469. Epub 2008 Nov 24. Blood. 2009. PMID: 19029441 Free PMC article.

9

A decade of R-CHOP.

Sehn LH. Sehn LH. Blood. 2010 Sep 23;116(12):2000-1. doi: 10.1182/blood-2010-07-293407. Blood. 2010. PMID: 20864584 Free article. No abstract available.

10

An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era.

Zhou Z, Sehn LH, Rademaker AW, Gordon LI, Lacasce AS, Crosby-Thompson A, Vanderplas A, Zelenetz AD, Abel GA, Rodriguez MA, Nademanee A, Kaminski MS, Czuczman MS, Millenson M, Niland J, Gascoyne RD, Connors JM, Friedberg JW, Winter JN. Zhou Z, et al. Among authors: sehn lh. Blood. 2014 Feb 6;123(6):837-42. doi: 10.1182/blood-2013-09-524108. Epub 2013 Nov 21. Blood. 2014. PMID: 24264230 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

246 results

Search Page